摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-碘嘧啶 | 31462-54-1

中文名称
2-碘嘧啶
中文别名
——
英文名称
2-iodopyrimidine
英文别名
2-Jodpyrimidin
2-碘嘧啶化学式
CAS
31462-54-1
化学式
C4H3IN2
mdl
MFCD09835340
分子量
205.986
InChiKey
AXDGIPMYJALRKV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    30-32 °C
  • 沸点:
    277.4±23.0 °C(Predicted)
  • 密度:
    2.102±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933599090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    存放在惰性气体中,并避免与空气接触;适宜温度为0至10℃。

SDS

SDS:67f4c7e5a2bf64cfc5e80b79c52ab47a
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Iodopyrimidine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Iodopyrimidine
CAS number: 31462-54-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C4H3IN2
Molecular weight: 206.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-碘嘧啶bis(acetylacetonate)nickel(II)1,2-双(二苯基膦)乙烷 isopropyl magnesium chloride 作用下, 以 四氢呋喃 为溶剂, 反应 4.17h, 生成 PF-04136309中间体
    参考文献:
    名称:
    3-Cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
    摘要:
    本发明涉及公式I的3-环烷胺基吡咯烷衍生物:(其中R1、R2、R3、R4、R5、R6、R7、X、Y和Z如本文所定义),这些衍生物可用作化学因子受体活性的调节剂。特别是,这些化合物可用作化学因子受体的调节剂,更具体地作为CCR2和/或CCR5受体的调节剂。本发明的化合物和组合物可能结合化学因子受体,例如CCR2和/或CCR5化学因子受体,并且可用于治疗与化学因子(例如CCR2和/或CCR5)活性相关的疾病,如动脉粥样硬化、再狭窄、狼疮、器官移植排斥和类风湿性关节炎。
    公开号:
    US20050192302A1
  • 作为产物:
    描述:
    嘧啶 在 magnesium bromide 、 2,2,6,6-tetramethylpiperidinylzinc bromide lithium bromide complex 、 作用下, 以 四氢呋喃 为溶剂, 反应 12.08h, 以97%的产率得到2-碘嘧啶
    参考文献:
    名称:
    [EN] CHEMICAL PROCESS
    [FR] PROCÉDÉ CHIMIQUE
    摘要:
    本发明提供了一种生产化合物的方法,该化合物的化学式为(I),其中取代基如权利要求1所定义。本发明还提供了在该方法中使用的中间化合物,以及生产该中间化合物的方法。
    公开号:
    WO2021234081A1
  • 作为试剂:
    描述:
    8-(5-溴吡啶-2-基)-1,4-二氧杂螺[4.5]癸烷-8-醇 、 2-碘嘧啶2-碘嘧啶 作用下, 生成 PF-04136309中间体
    参考文献:
    名称:
    ACS Med. Chem. Lett. 2011, 2, 913-918
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Cobalt-Catalyzed Preparation of N-Heterocyclic Organozinc Reagents from the Corresponding Heteroaryl Chlorides
    作者:Paul Knochel、Alexander Kremsmair、Simon Graßl、Christoph J. B. Seifert、Edouard Godineau
    DOI:10.1055/a-1534-0624
    日期:2021.11
    Various substituted and unsubstituted N-heteroaryl chlorides have been converted into their corresponding organozinc species using zinc dust in the presence of zinc pivalate and 10% CoCl2 in benzonitrile at 25 °C. The resulting heteroarylzinc reagents were obtained in 43–98% yield within 9–48 h and reacted with a broad range of electrophiles, leading to the functionalized heteroarenes.
    在新戊酸锌和 10% CoCl2 的苄腈溶液中,在 25 °C 下,使用锌粉将各种取代和未取代的 N-杂芳基氯化物转化为相应的有机锌物质。得到的杂芳基锌试剂在 9-48 小时内以 43-98% 的产率获得,并与广泛的亲电子试剂反应,产生功能化的杂芳烃。
  • 一种2-羟基-5-磺酸基嘧啶的制备方法
    申请人:南京竹园医药科技有限公司
    公开号:CN111484458B
    公开(公告)日:2022-12-27
    本发明公开了一种2‑羟基‑5‑磺酸基嘧啶的简易制备方法。该方法以2‑卤代嘧啶为原料,在一定温度下同氯磺酸反应,实现2‑羟基‑5‑磺酸基嘧啶的直接制备,反应结束后静置过夜,产品经过滤、有机溶剂洗涤、干燥得2‑羟基‑5‑磺酸基嘧啶纯品,该工艺具有反应条件温和、操作过程简单、产物收率高等优点,适合工业规模生产,为相关化合物及其衍生物的制备提供了一条有效途径。
  • 一种光引发的合成3-芳基黄酮或香豆素类化合物的方法及应用
    申请人:云南大学
    公开号:CN111039910A
    公开(公告)日:2020-04-21
    本发明涉及一种光引发的合成3‑芳基黄酮或香豆素类化合物的方法及应用,该合成方法为,将黄酮类物质在碱性条件下被可见光激发,与芳基卤化物发生单子转移反应引发自由基,一步生成3‑芳基黄酮衍生物。本发明通过利用黄酮和香豆素类化合物在碱性条件下的光反应活性,通过光激发的黄酮或香豆素类化合物与芳基卤化物之间发生单电子转移反应引发自由基,一步法合成3‑芳基黄酮或香豆素类化合物,方法简单、高效,原料和试剂便宜易得,反应产率高,副产物少,反应的化学和区域选择性高。
  • Process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols
    申请人:Mergelsberg Ingrid
    公开号:US20060058343A1
    公开(公告)日:2006-03-16
    The present invention relates to a process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols having the structural formula I or a pharmaceutically acceptable salt or solvate thereof, wherein R is benzyl, R 5 -benzyl, allyl, —C(O)R 6 , —C(O)OR 8 or —CH(R 7 ) 2 ; R 1 is optionally substituted aryl or optionally substituted heteroaryl; and R 5 , R 6 , R 7 and R 8 are as defined in the specification; comprising a) reacting an amine of formula II R—NH 2 II with 2,5-dimethoxytetrahydrofuran or HC(O)(CH 2 ) 2 C(O)H, and C(O)(CH 2 C(O)OR 4 ) 2 , wherein R 4 is H or alkyl, to obtain a compound of formula III b) reacting a compound of formula III with I-R 1 , alkyl lithium, and optionally a lithium salt, to obtain a compound of formula I; and c) optionally converting a compound of formula I wherein R is benzyl, R 5 -benzyl, allyl, —C(O)R 6 or —C(O)OR 6 to a compound of formula I wherein R is —CH(R 7 ) 2 . Intermediates in the process are also claimed.
    本发明涉及一种制备具有结构式I的取代8-氮杂双环[3.2.1]辛烷-3-醇或其药用可接受盐或溶剂的方法,其中R为苄基、R5-苄基、烯丙基、—C(O)R6、—C(O)OR8或—CH(R7)2;R1为可选择取代的芳基或可选择取代的杂芳基;以及R5、R6、R7和R8如规范中所定义;包括a)将式II的胺R—NH2与2,5-二甲氧基四氢呋喃或HC(O)(CH2)2C(O)H以及C(O)(CH2C(O)OR4)2反应,其中R4为H或烷基,以获得式III的化合物;b)将式III的化合物与I-R1、烷基锂和可选择的锂盐反应,以获得式I的化合物;以及c)可选择地将式I的化合物(其中R为苄基、R5-苄基、烯丙基、—C(O)R6或—C(O)OR6)转化为式I的化合物(其中R为—CH(R7)2)。该方法中的中间体也受到保护。
  • Improved Synthesis of 2,2‘-Bipyrimidine
    作者:Gábor Vlád、István T. Horváth
    DOI:10.1021/jo0255781
    日期:2002.9.1
    A high-yield synthesis was developed for the preparation of 2,2'-bipyrimidine (1) using the Ullmann coupling of 2-iodopyrimidine. The new procedure was also used for the preparation of 4,4',6,6'-tetramethyl-2,2'-bipyrimidine (2) and 5,5'-dibromo-2,2'-bipyrimidine (3).
    利用2-碘嘧啶的Ullmann偶联,开发了用于制备2,2'-联嘧啶(1)的高产率合成。该新方法还用于制备4,4',6,6'-四甲基-2,2'-联嘧啶(2)和5,5'-二溴-2,2'-联嘧啶(3)。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台